Envitas AAIT - a Powerful Immunotherapy                   for CancerAAIT is an acronym for autologous adoptive immune ther...
1) Envitas protocol for AAIT is primed to optimize the expansion of natural killer cells –the single most potent cancer fi...
Upcoming SlideShare
Loading in …5
×

Envita's AAIT - a Powerful Immunotherapy for Cancer

326 views
251 views

Published on

http://www.envita.com/conditions-we-treat/cancer/immunotherapy/ - Immunotherapy for Cancer Treatment is absolutely necessary, and many are lacking it. At Envita, it is not an afterthought but in fact, our focus. The immune system is the first and last defense against cancer, and we believe to be critical for long-term success.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
326
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Envita's AAIT - a Powerful Immunotherapy for Cancer

  1. 1. Envitas AAIT - a Powerful Immunotherapy for CancerAAIT is an acronym for autologous adoptive immune therapy and defines a therapyderived from a patient’s own blood, which is re-infused during cancer treatment. Thereare abundant strategies for immunotherapy and just as many treatments that can bereferenced as “autologous adoptive immunotherapy.” Clearly, not all options aredeemed comparable.Envita’s immunotherapy, AAIT, involves 4 major cell types which include: • Natural killer cells • Natural killer T cells • Cytokine-induced killer cells • Cytotoxic T lymphocytesThe inclusion of Natural killer cells (NKs) and Natural killer T cells (NKTs) are thepredominant focus of Envita’s AAIT immunotherapy serums.Natural Killer Cells Important in Cancer Prognosis of CancerWhen NK cell numbers and functionality are low, cancer patients are predisposed tomore aggressive tumor growth. And, as disease progresses, such declines are likely tocontinue. In both animal and human clinical trials, we have seen that by restoring NKand NKT function leads to enhanced cellular immune tumor-response and higherpatient survival rates.Keys to Envitas AAIT Uniqueness
  2. 2. 1) Envitas protocol for AAIT is primed to optimize the expansion of natural killer cells –the single most potent cancer fighting component of the cellular immune system. Mostimmune therapies do, in fact, include natural killer cells, yet those that do, simplyexpand them in minimal amounts with little activation.2) Envitas AAIT protocol requires only four to five weeks to grow your cells, so you can,with a degree of certainty, experience benefits within short duration - while otherimmunotherapy approaches call to administer just 100-200 million cells per treatment,Envita delivers roughly 100 times as many during the sojourn of treatment.3) Stockpiles of published studies convey the effects of adoptive immune therapy incancer patients, wherein Envita has identified and improved upon the very best.Company protocol demands the highest level of procedure for the expansion andapplication of cells for each immunotherapy treatment.4) Unlike other publications regarding immune therapies, Envitas AAIT immunotherapyendorses the only one that can be used as a “stand-alone.” Moreover, it may also beadministered in conjunction with other therapies to enhance the cells’ effects in patients– an enviable benefit. Envitas AAIT immunotherapy is not focused solely on expandingcells in the laboratory: rather, our aim also includes keeping them active, until whichtime, they are reintroduced into the patient’s body.5) Envita’s AAIT immunotherapy unleashes far greater tumor destruction, or cytotoxicitythan that of other well-regarded cancer cell vaccines / immunotherapy treatments foundrandomly throughout the world. In essence, this indicates that Envita’s activated naturalkiller cells in AAIT deliver considerably higher tumor obliteration. 6) In summation, the most direct manner with which to contrast Envita’s proprietary immunotherapy against the others includes its: a. Quality - based on cytoxicity (how much tumor the immune system can marginalize). Envita’s AAIT immunotherapy consistently delivers “significantly greater tumor kill”. b. Quantity (how many cells you get back) – Envita’s AAIT immunotherapy battles with 100 times the cell dosage than those others. c. Sterility (quality control measures) – Envita AAIT immunotherapy is completely free of contaminants. Any questions concerning Envitas AAIT immunotherapy may be addressed during consultation with Envitas superb team of physicians and patient educators. This immunotherapy is offered at Envita’s international cancer center in Mexico.

×